Author:
Park Woo-Jae,Park Joo-Won
Abstract
Abstract
Sphingolipids have emerged as an important lipid mediator in intracellular signalling and metabolism. Ceramide, which is central to sphingolipid metabolism, is generated either via a de novo pathway, by attaching fatty acyl CoA to a long-chain base, or via a salvage pathway, by degrading pre-existing sphingolipids. As a ‘sphingolipid rheostat’ has been proposed, the balance between ceramide and sphingosine-1-phosphate has been the object of considerable attention. Ceramide has recently been reported to have a different function depending on its acyl chain length: six ceramide synthases (CerS) determine the specific ceramide acyl chain length in mammals. All CerS-deficient mice generated to date show that sphingolipids with defined acyl chain lengths play distinct pathophysiological roles in disease models. This review describes recent advances in understanding the associations of CerS with various diseases and includes clinical case reports.
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference178 articles.
1. Genetic loci associated with circulating levels of very long - chain saturated fatty acids;Lemaitre;Lipid Res
2. Mechanisms by which permeabilise mitochondria during apoptosis;Dewson;Cell Sci,2009
3. Visualization of ceramide channels by transmission electron microscopy;Samanta;Biochim Biophys Acta,2011
4. wide association study identifies genetic risk underlying primary rhegmatogenous retinal detachment;Kirin;Genome Hum Mol Genet,2013
5. The complexity of sphingolipid biosynthesis in the endoplasmic reticulum;Tidhar;Biochim Biophys Acta,2013
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献